CG
Cannon Global Investment Management, LLC
13F filer · CIK 0001844427Reported Jul 30, 2026
Net seller this quarter
13F portfolio value$35.4MU.S. long equity reported on 13F
Positions4817 new · 47 closed
Net flow last quarter-$17.1MBuys minus sells
Top 10 positions weight34.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 30, 202648 positions | |||||
| $2.08M | 5.87% | 0.00% | -5.7% | Q3 2025 | |
| $1.63M | 4.61% | 0.01% | +14.3% | Q3 2022 | |
| $1.6M | 4.52% | 0.00% | +166.7% | Q3 2025 | |
| $1.17M | 3.30% | Not reported | -17.2% | Q4 2024 | |
| CIGTLSChart Industries Inc | $1.04M | 2.96% | 0.01% | +28.2% | Q1 2022 |
| $1.01M | 2.85% | Not reported | +12.0% | Q1 2022 | |
| $952K | 2.69% | 0.02% | +44.0% | Q4 2025 | |
| $933K | 2.64% | 0.02% | +209.0% | Q1 2021 | |
| $890K | 2.52% | Not reported | -8.4% | Q2 2025 | |
| $860K | 2.43% | 0.17% | +97.0% | Q1 2026 | |
| EAEAElectronic Arts Inc. | $841K | 2.38% | Not reported | -31.7% | Q4 2025 |
| $807K | 2.28% | 0.00% | +13.3% | Q4 2022 | |
| $805K | 2.28% | 0.01% | +87.5% | Q1 2025 | |
| $794K | 2.24% | Not reported | +0.8% | Q3 2025 | |
| $791K | 2.24% | Not reported | New | Q2 2026 | |
| $753K | 2.13% | 0.00% | +4.2% | Q1 2026 | |
| $749K | 2.12% | 0.00% | -52.9% | Q1 2026 | |
| $706K | 2.00% | 0.01% | -11.7% | Q4 2025 | |
| $693K | 1.96% | 0.05% | New | Q2 2026 | |
| $681K | 1.93% | 0.09% | New | Q2 2026 | |
| $617K | 1.74% | 0.00% | New | Q2 2026 | |
| HCHVIIHennessy Capital Investment Corp. VII | $610K | 1.73% | Not reported | +0.7% | Q4 2025 |
| $608K | 1.72% | Not reported | +45.8% | Q3 2025 | |
| $597K | 1.69% | 0.02% | +124.4% | Q1 2026 | |
| $568K | 1.61% | 0.00% | +12.5% | Q2 2023 | |
| $568K | 1.61% | 0.01% | New | Q2 2026 | |
| $559K | 1.58% | 0.04% | New | Q2 2026 | |
| $535K | 1.51% | 0.03% | -15.6% | Q1 2026 | |
| $531K | 1.50% | 0.00% | Not reported | Q2 2025 | |
| $493K | 1.39% | 0.00% | New | Q2 2026 | |
| $444K | 1.26% | Not reported | New | Q2 2026 | |
| $442K | 1.25% | 0.56% | +1.0% | Q3 2025 | |
| $434K | 1.23% | Not reported | -58.3% | Q2 2025 | |
| $389K | 1.10% | 0.00% | +10.4% | Q3 2024 | |
| $370K | 1.05% | 0.02% | -45.3% | Q1 2026 | |
| $340K | 0.96% | 0.00% | New | Q2 2026 | |
| $326K | 0.92% | Not reported | New | Q2 2026 | |
| $306K | 0.87% | Not reported | +1.3% | Q2 2025 | |
| WFWBSWebster Financial Corp | $306K | 0.86% | 0.00% | New | Q2 2026 |
| $301K | 0.85% | 0.01% | Not reported | Q3 2024 | |
| $274K | 0.78% | 0.02% | New | Q2 2026 | |
| $272K | 0.77% | 0.00% | Not reported | Q2 2025 | |
| $260K | 0.74% | 0.01% | Not reported | Q4 2025 | |
| $213K | 0.60% | Not reported | +5.7% | Q4 2025 | |
| $181K | 0.51% | 0.01% | New | Q2 2026 | |
| TBTBPHTheravance Biopharma, Inc. | $175K | 0.50% | 0.02% | -35.7% | Q3 2022 |
| $137K | 0.39% | Not reported | +1.6% | Q4 2025 | |
| $23.3K | 0.07% | Not reported | -73.0% | Q2 2025 | |
| Q1 2026Reported Apr 21, 202678 positions | |||||
| $2.01M | 3.92% | 0.00% | +12.9% | Q3 2025 | |
| $1.5M | 2.93% | 0.01% | Not reported | Q3 2022 | |
| $1.45M | 2.83% | 0.00% | -7.3% | Q3 2023 | |
| $1.38M | 2.69% | 0.02% | New | Q1 2026 | |
| $1.31M | 2.56% | Not reported | +23.5% | Q4 2024 | |
| $1.24M | 2.42% | Not reported | +15.1% | Q2 2025 | |
| EAEAElectronic Arts Inc. | $1.22M | 2.39% | Not reported | +445.5% | Q4 2025 |
| $1.02M | 1.99% | Not reported | +15.7% | Q1 2022 | |
| $971K | 1.90% | 0.00% | -40.6% | Q4 2025 | |
| CECEPTCantor Equity Partners II, Inc. | $958K | 1.87% | Not reported | +126.2% | Q2 2025 |
| $953K | 1.86% | Not reported | +21.9% | Q2 2025 | |
| $946K | 1.85% | 0.01% | +62.8% | Q3 2022 | |
| CECAEPCantor Equity Partners III, Inc. | $864K | 1.69% | Not reported | +13.2% | Q2 2025 |
| $827K | 1.61% | 0.00% | New | Q1 2026 | |
| CIGTLSChart Industries Inc | $806K | 1.57% | 0.01% | +18.2% | Q1 2022 |
| $794K | 1.55% | 0.00% | New | Q1 2026 | |
| $771K | 1.51% | Not reported | +16.5% | Q3 2025 | |
| $765K | 1.49% | 0.01% | +119.2% | Q3 2024 | |
| $738K | 1.44% | 0.04% | New | Q1 2026 | |
| $723K | 1.41% | 0.02% | New | Q1 2026 | |
| $700K | 1.37% | 0.00% | Not reported | Q4 2022 | |
| $668K | 1.30% | 0.01% | +175.0% | Q4 2025 | |
| $662K | 1.29% | 0.01% | New | Q1 2026 | |
| $629K | 1.23% | 0.01% | -63.2% | Q4 2025 | |
| $618K | 1.21% | 0.00% | -60.5% | Q3 2025 | |
| $613K | 1.20% | 0.10% | New | Q1 2026 | |
| HCHVIIHennessy Capital Investment Corp. VII | $600K | 1.17% | Not reported | +14.2% | Q4 2025 |
| $581K | 1.13% | 0.05% | New | Q1 2026 | |
| $530K | 1.03% | Not reported | Not reported | Q2 2025 | |
| $525K | 1.03% | 0.00% | Not reported | Q2 2023 | |
| $522K | 1.02% | 0.03% | New | Q1 2026 | |
| $521K | 1.02% | 0.00% | New | Q1 2026 | |
| CACWANClearwater Analytics Holdings, Inc. | $494K | 0.97% | Not reported | Not reported | Q1 2024 |
| $492K | 0.96% | 0.04% | New | Q1 2026 | |
| TPTERNTerns Pharmaceuticals, Inc. | $474K | 0.93% | 0.01% | New | Q1 2026 |
| $452K | 0.88% | 0.06% | New | Q1 2026 | |
| $428K | 0.84% | 0.01% | New | Q1 2026 | |
| $427K | 0.83% | 0.56% | +12.7% | Q3 2025 | |
| $419K | 0.82% | 0.00% | +14.3% | Q1 2025 | |
| $417K | 0.81% | Not reported | New | Q1 2026 | |
| $409K | 0.80% | 0.08% | New | Q1 2026 | |
| $408K | 0.80% | 0.04% | +32.1% | Q3 2025 | |
| $407K | 0.80% | 0.00% | Not reported | Q3 2024 | |
| $387K | 0.76% | 0.04% | Not reported | Q4 2021 | |
| $362K | 0.71% | 0.01% | New | Q1 2026 | |
| $360K | 0.70% | 0.02% | New | Q1 2026 | |
| $335K | 0.66% | 0.15% | +1630.1% | Q1 2026 | |
| $323K | 0.63% | Not reported | -25.0% | Q3 2025 | |
| $299K | 0.58% | 0.01% | -67.7% | Q3 2025 | |
| $299K | 0.58% | Not reported | +13.2% | Q2 2025 | |
| Q4 2025Reported Jan 27, 202657 positions | |||||
| $1.92M | 4.82% | 0.00% | New | Q4 2025 | |
| $1.79M | 4.50% | 0.00% | +6.9% | Q3 2025 | |
| $1.64M | 4.13% | 0.00% | -10.1% | Q3 2025 | |
| $1.4M | 3.52% | 0.00% | New | Q4 2025 | |
| $1.31M | 3.30% | 0.03% | New | Q4 2025 | |
| $1.14M | 2.86% | Not reported | +43.5% | Q4 2024 | |
| $1.08M | 2.71% | Not reported | Not reported | Q1 2022 | |
| $1.07M | 2.69% | 0.00% | -24.7% | Q3 2023 | |
| $1.07M | 2.68% | Not reported | +14.1% | Q2 2025 | |
| ABRNAMAvidity Biosciences, Inc. | $1.05M | 2.63% | 0.01% | New | Q4 2025 |
| $1.04M | 2.61% | 0.00% | -1.5% | Q3 2023 | |
| $1M | 2.52% | 0.03% | -43.0% | Q3 2025 | |
| $958K | 2.41% | 0.01% | Not reported | Q3 2024 | |
| $949K | 2.38% | 0.13% | New | Q4 2025 | |
| $812K | 2.04% | Not reported | +11.4% | Q2 2025 | |
| CECAEPCantor Equity Partners III, Inc. | $755K | 1.90% | Not reported | +81.8% | Q2 2025 |
| $752K | 1.89% | 0.00% | -9.5% | Q3 2022 | |
| $748K | 1.88% | 0.00% | -28.3% | Q3 2024 | |
| $747K | 1.88% | 0.01% | -17.0% | Q4 2023 | |
| $736K | 1.85% | Not reported | +79.6% | Q3 2025 | |
| $694K | 1.74% | 0.01% | New | Q4 2025 | |
| DDAYDayforce, Inc. | $692K | 1.74% | 0.01% | Not reported | Q3 2021 |
| CIGTLSChart Industries Inc | $681K | 1.71% | 0.01% | +3.1% | Q1 2022 |
| $670K | 1.68% | 0.00% | +7.1% | Q4 2024 | |
| $668K | 1.68% | Not reported | +21.9% | Q3 2025 | |
| $610K | 1.53% | 0.01% | +200.0% | Q2 2025 | |
| $598K | 1.50% | 0.01% | New | Q4 2025 | |
| $595K | 1.50% | 0.01% | New | Q4 2025 | |
| $587K | 1.48% | 0.01% | +10.0% | Q3 2024 | |
| $556K | 1.40% | 0.00% | New | Q4 2025 | |
| $533K | 1.34% | 0.01% | New | Q4 2025 | |
| $526K | 1.32% | 0.00% | -4.5% | Q3 2024 | |
| HCHVIIHennessy Capital Investment Corp. VII | $526K | 1.32% | Not reported | New | Q4 2025 |
| TTGNATegna Inc | $485K | 1.22% | Not reported | New | Q4 2025 |
| $455K | 1.14% | 0.01% | Not reported | Q1 2022 | |
| $439K | 1.10% | 0.01% | Not reported | Q2 2023 | |
| CECEPTCantor Equity Partners II, Inc. | $438K | 1.10% | Not reported | -16.7% | Q2 2025 |
| $409K | 1.03% | 0.03% | -26.5% | Q3 2025 | |
| $408K | 1.02% | 0.00% | -12.5% | Q1 2025 | |
| $404K | 1.02% | 0.03% | New | Q4 2025 | |
| $392K | 0.98% | 0.00% | -48.7% | Q3 2024 | |
| $381K | 0.96% | 0.03% | -48.3% | Q3 2025 | |
| $375K | 0.94% | 0.49% | +55.8% | Q3 2025 | |
| $324K | 0.81% | 0.00% | -45.8% | Q3 2024 | |
| $297K | 0.75% | 0.01% | New | Q4 2025 | |
| $294K | 0.74% | 0.00% | New | Q4 2025 | |
| COCIOCity Office REIT, Inc. | $280K | 0.70% | 0.10% | New | Q4 2025 |
| KKWKennedy-Wilson Holdings, Inc. | $266K | 0.67% | 0.02% | New | Q4 2025 |
| $265K | 0.66% | Not reported | +25.0% | Q2 2025 | |
| $259K | 0.65% | 0.00% | Not reported | Q2 2025 | |
| Q3 2025Reported Oct 28, 202558 positions | |||||
| $1.74M | 2.62% | 0.00% | New | Q3 2025 | |
| $1.74M | 2.62% | 0.01% | +80.0% | Q3 2022 | |
| $1.72M | 2.58% | 0.00% | +32.7% | Q3 2023 | |
| $1.53M | 2.31% | 0.00% | Not reported | Q3 2023 | |
| $1.44M | 2.17% | 0.05% | New | Q3 2025 | |
| $1.24M | 1.86% | 0.00% | New | Q3 2025 | |
| $1.16M | 1.75% | 0.00% | Not reported | Q3 2022 | |
| $1.08M | 1.62% | 0.01% | +8.0% | Q4 2022 | |
| $1.02M | 1.53% | 0.00% | Not reported | Q4 2024 | |
| $981K | 1.47% | 0.00% | -13.3% | Q3 2023 | |
| $958K | 1.44% | Not reported | -33.1% | Q1 2021 | |
| $939K | 1.41% | Not reported | +62.7% | Q2 2025 | |
| $884K | 1.33% | 0.01% | -18.5% | Q3 2024 | |
| $857K | 1.29% | 0.06% | New | Q3 2025 | |
| $843K | 1.27% | 0.00% | Not reported | Q3 2022 | |
| $834K | 1.25% | 0.00% | +55.6% | Q4 2024 | |
| $825K | 1.24% | 0.00% | Not reported | Q2 2025 | |
| $799K | 1.20% | 0.00% | Not reported | Q2 2025 | |
| $799K | 1.20% | Not reported | Not reported | Q4 2021 | |
| $769K | 1.16% | 0.01% | Not reported | Q4 2023 | |
| $759K | 1.14% | Not reported | Not reported | Q4 2024 | |
| $745K | 1.12% | Not reported | +148.4% | Q2 2025 | |
| $722K | 1.08% | 0.00% | +4.7% | Q3 2024 | |
| $662K | 1.00% | 0.01% | -45.8% | Q3 2024 | |
| $648K | 0.97% | 0.00% | New | Q3 2025 | |
| CIGTLSChart Industries Inc | $640K | 0.96% | 0.01% | Not reported | Q1 2022 |
| $636K | 0.96% | 0.02% | +84.6% | Q3 2024 | |
| $618K | 0.93% | 0.01% | -40.8% | Q2 2025 | |
| $610K | 0.92% | 0.01% | Not reported | Q3 2024 | |
| $610K | 0.92% | 0.00% | Not reported | Q1 2025 | |
| $575K | 0.86% | 0.01% | -49.6% | Q3 2023 | |
| $569K | 0.85% | 0.01% | -11.1% | Q3 2024 | |
| $561K | 0.84% | 0.00% | +13.6% | Q4 2022 | |
| $557K | 0.84% | 0.01% | -44.0% | Q2 2025 | |
| $548K | 0.82% | 0.00% | -6.7% | Q2 2025 | |
| $543K | 0.82% | Not reported | New | Q3 2025 | |
| $533K | 0.80% | 0.00% | New | Q3 2025 | |
| $512K | 0.77% | Not reported | +28.6% | Q1 2025 | |
| CECEPTCantor Equity Partners II, Inc. | $491K | 0.74% | Not reported | +108.6% | Q2 2025 |
| $478K | 0.72% | 0.01% | Not reported | Q3 2023 | |
| $459K | 0.69% | 0.01% | +57.9% | Q2 2025 | |
| CECAEPCantor Equity Partners III, Inc. | $420K | 0.63% | Not reported | +239.2% | Q2 2025 |
| $410K | 0.62% | Not reported | New | Q3 2025 | |
| $379K | 0.57% | 0.00% | Not reported | Q2 2023 | |
| $367K | 0.55% | 0.00% | Not reported | Q1 2025 | |
| $361K | 0.54% | 0.01% | -23.1% | Q4 2024 | |
| $352K | 0.53% | 0.01% | New | Q3 2025 | |
| CCCCRNCross Country Healthcare Inc | $351K | 0.53% | 0.08% | New | Q3 2025 |
| $346K | 0.52% | 0.01% | Not reported | Q3 2024 | |
| $329K | 0.49% | 0.01% | Not reported | Q2 2025 | |
Premium opens every quarter this fund has filed